Journal
Phase Theory Research
May 2, 2026 · 9 min read
You started a new medication and, three months later, your hair started falling out. You might not connect the two — but the relationship between certain prescription drugs and hair loss is well-documented in dermatology, even if it's rarely discussed at the prescribing appointment.
Drug-induced hair loss occurs through two primary mechanisms. The first is anagen effluvium — where the medication disrupts the active growth phase, causing hairs to shed within days to weeks of starting treatment. This is characteristic of chemotherapy but also occurs with some immunosuppressants. The second is telogen effluvium — where the drug triggers a mass shift of follicles into the resting (telogen) phase, producing significant shedding 2–4 months after exposure begins.
Blood thinners (anticoagulants) including warfarin and heparin are among the most commonly reported causes of drug-induced hair loss, affecting up to 50% of long-term users. The mechanism involves disruption of the microvasculature that feeds the follicle.
Antidepressants — particularly SSRIs (fluoxetine, sertraline, paroxetine) and SNRIs — carry hair loss as a documented side effect. The mechanism is not fully understood but may involve serotonin-mediated changes in the hair cycle regulatory pathways.
Beta-blockers (metoprolol, propranolol, atenolol), used for blood pressure and anxiety, are linked to telogen effluvium through their effect on peripheral circulation — reducing blood flow to the scalp and compromising follicle nourishment.
Hormonal medications — including birth control pills, particularly those with androgenic progestins, and hormone replacement therapy — can trigger hair shedding in women genetically sensitive to androgen activity. Some women only notice hair loss when they stop the pill, as the hormonal shift triggers a synchronized telogen effluvium.
Cholesterol-lowering statins, thyroid medications (when dose is imprecise), retinoids (vitamin A derivatives used for acne), and some anticonvulsants are additional common contributors.
Never discontinue a medication without consulting your prescriber. But do have an informed conversation — ask whether hair loss is a documented side effect and whether an alternative within the same drug class exists. Many drug classes have members with lower androgenic activity or lesser follicular impact.
Topically, maintaining scalp health through anti-inflammatory care (rosemary, peppermint, reduced sulfate exposure) supports follicle resilience during pharmacological stress. Supporting iron and zinc levels is important, as many medications deplete these nutrients as a secondary effect.
Share this article
Phase Theory Research
Phase Theory Beauty Co.
Shop the Science
Products formulated with the actives featured in this article.